Regenerative medicine corporations L&C BIO said on the 22nd that at the MSAAH Congress 2026, an international event in Myanmar for aesthetic medicine, anti-aging, and hair regeneration, it held a launch session for the company's flagship skin booster, Re2O.
A skin booster is a procedure or product that improves the skin by applying or injecting active ingredients that help with skin regeneration, wrinkle improvement, and brightening.
Lee Ju-hee, a special-appointment professor at Yonsei University College of Medicine and vice chair at L&C BIO, who served as a speaker for this session, defined skin aging as the collapse of the ECM microenvironment and emphasized the need for a regeneration-based approach. Shin Dong-woo, director at Nabi Plastic Surgery, presented real-world application experiences focused on clinical cases based on acellular dermal matrix.
Su Phyo Aung, director in Myanmar who served as the session moderator, said of Re2O, "the ECM skin booster with the strongest preclinical and clinical evidence," and noted, "going forward, we will expand its use locally not only for skin regeneration but also into the hair regeneration field."
L&C BIO Chair Lee Hwan-chul said, "The global aesthetic medicine market is rapidly shifting from simple volume augmentation to a focus on structural and functional restoration," adding, "Re2O is accelerating global expansion with an ECM-based platform." Lee went on to say, "Following the Singapore launch, adoption in the Asian market is expanding, and by the end of the year we plan to continue spreading K-regenerative aesthetic medicine in about 20 countries."